Cargo Therapeutics Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
102
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$247M
Cargo Therapeutics General Information
Description
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
Contact Information
Website
www.cargo-tx.comCorporate Office
- 835 Industrial Road
- Suite 400
- San Carlos, CA 94070
- United States
Corporate Office
- 835 Industrial Road
- Suite 400
- San Carlos, CA 94070
- United States
Cargo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 18-Aug-2025 | $247M | Completed | Generating Revenue | ||
| 4. PIPE | 12-Aug-2024 | Completed | Generating Revenue | |||
| 3. IPO | 10-Nov-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 09-Feb-2023 | $212M | $224M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 26-Apr-2022 | $12M | $12M | Completed | Startup |
Cargo Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Seed | 11,000,000 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 4.43% |
Cargo Therapeutics Comparisons
Industry
Financing
Details
Cargo Therapeutics Competitors (2)
One of Cargo Therapeutics’s 2 competitors is Kyverna, a Formerly VC-backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kyverna | Formerly VC-backed | Emeryville, CA | ||||
| Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA |
Cargo Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cargo Therapeutics Patents
Cargo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136970-A1 | Methods for manufacturing car t cells | Pending | 20-Dec-2024 | ||
| WO-2025231191-A1 | Compositions and methods for allogeneic immune cells | Pending | 01-May-2024 | ||
| EP-4798625-A1 | Modified immune effector cells | Pending | 26-Oct-2023 | ||
| WO-2025090978-A1 | Modified immune effector cells | Inactive | 26-Oct-2023 | ||
| WO-2025085680-A1 | Methods for manufacturing car t cells | Inactive | 17-Oct-2023 | A61P35/00 |
Cargo Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cargo Therapeutics Former Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ally Bridge Group | Growth/Expansion | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Cormorant Capital | Real Estate | Minority | ||
| EcoR1 Capital | Venture Capital | Minority | ||
| Emerson Collective | Impact Investing | Minority |
Cargo Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Cargo Therapeutics FAQs
-
When was Cargo Therapeutics founded?
Cargo Therapeutics was founded in 2019.
-
Where is Cargo Therapeutics headquartered?
Cargo Therapeutics is headquartered in San Carlos, CA.
-
What is the size of Cargo Therapeutics?
Cargo Therapeutics has 102 total employees.
-
What industry is Cargo Therapeutics in?
Cargo Therapeutics’s primary industry is Drug Discovery.
-
Is Cargo Therapeutics a private or public company?
Cargo Therapeutics is a Private company.
-
What is the current valuation of Cargo Therapeutics?
The current valuation of Cargo Therapeutics is .
-
What is Cargo Therapeutics’s current revenue?
The current revenue for Cargo Therapeutics is .
-
How much funding has Cargo Therapeutics raised over time?
Cargo Therapeutics has raised $616M.
-
Who are Cargo Therapeutics’s investors?
Ally Bridge Group, Cormorant Asset Management, Cormorant Capital, EcoR1 Capital, and Emerson Collective are 5 of 22 investors who have invested in Cargo Therapeutics.
-
Who are Cargo Therapeutics’s competitors?
Kyverna and Allogene Therapeutics are competitors of Cargo Therapeutics.
-
When was Cargo Therapeutics acquired?
Cargo Therapeutics was acquired on 18-Aug-2025.
-
Who acquired Cargo Therapeutics?
Cargo Therapeutics was acquired by Concentra Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
